P2.04-91 Target Antigen Levels in NSCLC Define a Clinically Relevant Activation Threshold for NY-ESO-1c259 TCR T-Cell Therapy

Autor:	Ioanna Eleftheriadou, Lea Patasic, Junping Jing, A. Domogala, K. Soor, L. Castelletti, S. O’sullivan, J. Klapwijk, L. Johnsons, Aiman Shalabi, S. Brett, M. Damm, K.R. Auger, C. Britten, J. Euesden, D. Pankov, J. Spaull, M.A. Kijewska, R. Roberts
Rok vydání:	2019
Předmět:	Pulmonary and Respiratory Medicine medicine.anatomical_structure Oncology business.industry T cell T-cell receptor Cancer research medicine business Target antigen
Zdroj:	Journal of Thoracic Oncology. 14:S745-S746
ISSN:	1556-0864
DOI:	10.1016/j.jtho.2019.08.1596
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::615c5625f91a4af8ee39c2a775c373f3 https://doi.org/10.1016/j.jtho.2019.08.1596 Zobrazit plný text záznamu